Uremic Toxins and Cardiovascular System

Area of Science:

• Nephrology
• Cardiology
• Toxicology

Background:

• Chronic kidney disease (CKD) impairs the kidneys' ability to excrete metabolic waste products.
• This leads to the accumulation of uremic toxins, which disrupt biological functions and can cause cardiovascular damage.
• Several uremic toxins are implicated in cardiovascular complications associated with CKD.

Purpose of the Study:

• To review the primary cardiotoxic mechanisms driven by uremic toxin retention in CKD.
• To identify the key uremic compounds responsible for these cardiotoxic effects.
• To discuss potential therapeutic strategies, including modulating intestinal microbiota.

Main Methods:

• Literature review of studies on chronic kidney disease, uremic toxins, and cardiovascular disease.
• Analysis of established cardiotoxic mechanisms linked to uremic toxin accumulation.
• Examination of therapeutic interventions targeting uremic toxin generation.

Main Results:

• Uremic toxin retention contributes to cardiotoxicity via endothelial dysfunction, vascular smooth muscle cell alterations, inflammation, mineral bone disorder, insulin resistance, and increased thrombogenicity.
• Specific retention compounds are identified as major contributors to these detrimental effects.
• Therapeutic strategies focusing on reducing solute generation, particularly from intestinal microbiota, show promise.

Conclusions:

• Uremic toxins play a critical role in the cardiovascular complications of CKD.
• Understanding the specific mechanisms and responsible compounds is essential for targeted therapies.
• Interventions aimed at reducing the burden of uremic toxins, including those influenced by gut microbiota, represent a viable therapeutic avenue.